# Increased cortical thickness and decreased brain age among special operations veterans with blast TBI after a magnesium-ibogaine protocol

**Authors:** Andrew D. Geoly, John P. Coetzee, Derrick Matthew Buchanan, Wiebke Struckmann, Bora Kim, Malvika Sridhar, Azeezat Azeez, Jennifer I. Lissemore, Kirsten Cherian, Afik Faerman, Jackob N. Keynan, Prakamya Singal, Alaa Shanbour, Igor D. Bandeira, Ian H. Kratter, Maheen M. Adamson, Manish Saggar, Cammie Rolle, Nolan R. Williams

PMC · DOI: 10.1016/j.isci.2026.115121 · 2026-02-21

## TL;DR

A treatment combining magnesium and ibogaine was linked to brain structure improvements in veterans with blast-induced TBI, suggesting potential for neuroplastic recovery.

## Contribution

This study is the first to show that magnesium-ibogaine therapy may reverse brain aging and enhance cortical thickness in blast TBI patients.

## Key findings

- Cortical thickness increased in 11 brain regions after magnesium-ibogaine treatment.
- Predicted brain age decreased by an average of 1.3 years at one month post-treatment.
- Subcortical volume expanded in cerebellar, forebrain, and diencephalic regions following treatment.

## Abstract

Ibogaine is a psychoactive alkaloid with therapeutic potential that may promote neuroplasticity. Its effects on human brain morphometry are unknown. Thirty Special Operations Forces veterans with prior blast-induced TBI participated in an observational study in which they received ibogaine co-administered with magnesium. Structural MRIs were collected at baseline (n = 25), initial post-treatment (n = 25), and 1-month post (n = 22). Longitudinal analyses assessed cortical thickness, subcortical volume, and predicted brain age (pBA), estimated from T1 scans. pBA was significantly reduced at 1 month relative to baseline (−1.3 years). Cortical thickness analysis revealed post-treatment increases in 11 regions. Subcortical analyses revealed significant volumetric expansion in 8 regions. Magnesium-ibogaine therapy was associated with increased cortical thickness, subcortical expansion, and reduced pBA at 1 month. Although T1s are sensitive to nonstructural changes, the overall direction of effect is consistent with neuroplastic change.

•Magnesium-ibogaine is associated with increased cortical thickness in veterans with blast TBI•Predicted brain age was reduced by a mean of ∼1.3 years at 1 month post-treatment•Subcortical volume expansion occurred in cerebellar, forebrain, and diencephalic regions•Findings compatible with increased structural neuroplasticity after magnesium-ibogaine

Magnesium-ibogaine is associated with increased cortical thickness in veterans with blast TBI

Predicted brain age was reduced by a mean of ∼1.3 years at 1 month post-treatment

Subcortical volume expansion occurred in cerebellar, forebrain, and diencephalic regions

Findings compatible with increased structural neuroplasticity after magnesium-ibogaine

Health sciences; Medicine; Medical specialty; Internal medicine; Neurology

## Linked entities

- **Chemicals:** ibogaine (PubChem CID 197060), magnesium (PubChem CID 5462224)

## Full-text entities

- **Diseases:** TBI (MESH:D000070642), blast (MESH:D001753)
- **Chemicals:** Magnesium (MESH:D008274), Ibogaine (MESH:D007050), psychoactive alkaloid (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13010113/full.md

---
Source: https://tomesphere.com/paper/PMC13010113